Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

3.38USD
14 Jun 2019
Change (% chg)

$-0.26 (-7.14%)
Prev Close
$3.64
Open
$3.62
Day's High
$3.62
Day's Low
$3.28
Volume
27,825
Avg. Vol
20,234
52-wk High
$13.87
52-wk Low
$3.22

Latest Key Developments (Source: Significant Developments)

Corvus Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
Thursday, 7 Mar 2019 

March 7 (Reuters) - Corvus Pharmaceuticals Inc ::CORVUS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.CORVUS PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.36.CORVUS PHARMACEUTICALS - AS OF DEC 31, 2018, CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES TOTALING $114.6 MILLION COMPARED TO $90.1 MILLION AT DEC 31, 2017.CORVUS PHARMACEUTICALS INC - COMPANY EXPECTS NET CASH UTILIZATION OF $43 MILLION TO $47 MILLION IN 2019.  Full Article

Corvus Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
Monday, 12 Mar 2018 

March 12 (Reuters) - Corvus Pharmaceuticals Inc ::CORVUS PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Corvus Pharmaceuticals reports third quarter 2017 financial results
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Corvus Pharmaceuticals Inc ::Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update.Net loss for three months ended September 30, 2017, was $12.7 million compared to $10.3 million for same period in 2016​.  Full Article